Guilloux Y, Bai X F, Liu X, Zheng P, Liu Y
Department of Pathology and Comprehensive Cancer Center, Ohio State University Medical Center, Columbus 43210 USA.
Cancer Res. 2001 Feb 1;61(3):1107-12.
MHC class I-restricted tumor antigen can be presented to CD8+ T cells by two distinct mechanisms. Direct presentation involves degradation of cytosolic proteins by the proteosome into peptides, transport of the peptides across the endoplasmic reticulum membrane, and expression of the MHC-peptide complex on the tumor cell surface. Cross-presentation, on the other hand, involves uptake and intracellular processing of the tumor antigen by host antigen-presenting cells. Whereas it is clear that cross-presentation is necessary and sufficient for the induction of memory CTLs, it has not been tested whether such presentation is sufficient to induce effector CTLs. Here we analyzed the requirements of direct antigen presentation for the induction of effector and memory antitumor CTLs using a MHC class I- mutant incapable of direct antigen presentation and its parent, the MHC class I+ J558 cell line. We report that in comparison with the MHC class I+ tumor cell, the MHC class I- mutant induces equal priming for recall CTL response but poor effector CTLs. Our results demonstrate that optimal induction of effector CTLs, but not memory CTLs, requires direct antigen presentation by the tumor cells.
MHC I类限制性肿瘤抗原可通过两种不同机制呈递给CD8+ T细胞。直接呈递涉及蛋白酶体将胞质蛋白降解为肽段,肽段跨内质网膜转运,以及MHC-肽复合物在肿瘤细胞表面表达。另一方面,交叉呈递涉及宿主抗原呈递细胞摄取并在细胞内加工肿瘤抗原。虽然很明显交叉呈递对于诱导记忆性CTL是必要且充分的,但这种呈递是否足以诱导效应性CTL尚未得到验证。在这里,我们使用一种无法进行直接抗原呈递的MHC I类突变体及其亲本MHC I+ J558细胞系,分析了直接抗原呈递对于诱导效应性和记忆性抗肿瘤CTL的要求。我们报告,与MHC I+肿瘤细胞相比,MHC I-突变体诱导回忆CTL反应的初始激发相同,但效应性CTL较差。我们的结果表明,效应性CTL的最佳诱导需要肿瘤细胞进行直接抗原呈递,而记忆性CTL则不需要。